Lucy Day

Lucy Day appears in our data through filings on AN2 Therapeutics, Inc. shares, published by SEC (Form 4). We count 6 filings; the first trade dates from 15 March 2024 and the latest from 20 February 2026.

Every open-market trade on record is a sale: 2 sales worth €6,685. The rest of the record consists of 4 share grants. So far in 2026, the count stands at no purchases and 1 sale.

On 23 February 2026 came the latest disclosure, a share grant in AN2 Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 3 days. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.